Oral ponesimod in relapsing-remitting multiple sclerosis: a randomised phase II trial. Olsson T, Boster A, Fernández O, Freedman MS, Pozzilli C, Bach D, Berkani O, Mueller MS, Sidorenko T, Radue E-W, et al. J Neurol Neurosurg Psychiatry. 2014 Mar 21. PMID: 24659797. Abstract CommentRecommendBookmarkWatch